Effects of Memantine, an NMDA Antagonist, on Metabolic Syndromes in Female NMRI Mice. 2015

Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

BACKGROUND The brain glutamate neurotransmitter system and its NMDA (N-methyl-D-aspartate) receptors in the nucleus accumbens play an important role in the incidence of sensitivity and addiction. The present study examined the inhibitory effect of glutamate NMDA receptors in the nucleus accumbens in response to chronic stress. METHODS After the unilateral and bilateral placement of cannula(e) in the nucleus accumbens, one group of the animals received different doses of intra-accumbens memantine (0.1, 0.5 and 1 μg/mouse) 5 minutes before receiving the electric shock stress at their soles (using a Communication Box) and the other group received intraperitoneal memantine (doses of 0.1, 0.5 and 1mg/kg) 30 minutes before receiving the same shock. Chronic stress increased the animals' weight, plasma corticosterone, food and water intake, but reduced their defecation rates and eating latency. RESULTS The intraperitoneal administration of memantine increased plasma corticosterone, water intake, fecal weight, and eating latency, but had no effect on food intake or weight. The dose and site-dependent intra-accumbens administration of memantine either exacerbated the effects of stress on plasma corticosterone levels, water and food intake, or had no effect on these parameters. Furthermore, the administration of memantine had no effect on animal's weight and inhibited the effects of stress on fecal weight and eating latency. CONCLUSIONS The inhibition of glutamate NMDA receptors in the nucleus accumbens can inhibit and/or exacerbate the dose and site-dependent effects of chronic stress, and gender plays a significant role in producing this effect too.

UI MeSH Term Description Entries

Related Publications

Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
May 2007, Brain research bulletin,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
April 2003, Methods and findings in experimental and clinical pharmacology,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
December 2002, Psychopharmacology,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
May 2003, Behavioural pharmacology,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
September 2016, Neuroscience letters,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
January 2014, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
June 2010, Georgian medical news,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
June 2023, Life sciences,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
May 2005, Behavioural pharmacology,
Naser Osanloo, and Nahid Sarahian, and Homeira Zardooz, and Hedayat Sahraei, and Mohammad Sahraei, and Bahareh Sadeghi
August 1998, European journal of pharmacology,
Copied contents to your clipboard!